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Abstract
Background: To define a threshold value of apparent diffusion coefficient (ADC) with which
malignant breast lesions can be distinguished from benign lesions, and to evaluate the ADC change
of peri-tumor tissue in breast carcinoma by echo planar-diffusion weighted imaging (EPI-DWI).
Methods: 57 breast lesions were scanned by routine MRI and EPI-DWI. The ADC values were
compared between malignant and benign lesions. The sensitivity and specificity of EPI-DWI and the
threshold ADC value were evaluated by Receiver Operating Characteristic curve (ROC). The
ADC values of malignant lesion and layered peri-tumor tissues (from innermost layer 1 to
outermost layer 4 with 5 mm every layer) in different directions were compared and the ADC
values among different layers were compared.
Results: The ADC value of 35 malignant lesions was statistically lower than that of 22 benign
lesions (P < 0.05). In ROC curve, the threshold value was 1.24 +/- 0.25*10E-3 mm2/s (b = 500) or
1.20 +/- 0.25*10E-3 mm2/s (b = 1000). The ADC value of malignant lesions was statistically lower
than that of peri-tumor tissues in different directions (P < 0.05). For peri-tumor tissues, the ADC
values increased gradually from layer 1 to layer 4 and there was a significant difference between the
ADC values of layer 1 and layer 2 (P < 0.05); while from layer 2 outwards, there was no statistical
difference among different layers.
Conclusion: ADC value was a sensitive and specific parameter that could help to differentiate
benign and malignant breast lesions. ADC changes in tissues adjacent to breast carcinoma could be
detected by EPI-DWI, which made EPI-DWI a promising method for helping to determine surgical
scope of breast carcinoma.
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Background
Conservative surgery has become a well-established alter-
native to mastectomy in the treatment of breast cancer.
However, in case of larger lesions or small-size breasts, the
removal of adequate volumes of breast tissue to achieve
tumor-free margins and reduce the risk of local relapse
may compromise the cosmetic outcome, causing unpleas-
ant results [1]. An issue of critical importance is thus to
know well the transition from the tumor tissue to normal
tissue in breast carcinoma in order to helpfully decide the
surgical scope. Currently, the evaluation of tumor scope in
clinical works relies on pathologic examination of mar-
gins free of gross tumor tissues. However, previous studies
reported that in some patients with histologically negative
margins, a relatively high recurrence rate was still
observed [2]. It was thought that genetic and molecular
alteration precedes phenotypic changes, therefore histo-
logic assessment alone may be inadequate to detect the
presence of transformed cells in surgical margins [3]. In
another word, histologic assessment alone may be insuf-
ficient for the detection of transition from the tumor tis-
sue to normal tissue. A recent study [4] discovered that
there existed the geographic zones of the normal tissue
adjacent to invasive cancers in which methylation changes
could be identified and the authors summarized that mul-
tiple gene promoters could be used as a surrogate biomar-
ker to define the molecular margin of lumpectomy in the
future. Studies of other malignant lesions [3,5-9], includ-
ing head and neck cancer, pancreatic cancer, lung cancer,
colorectal carcinoma, rectal cancer and hepatocellular car-
cinoma, also demonstrated that there existed a molecular
border of tumor tissues with various molecular methods.
However, all of these studies were performed on the
biopsy tissues or resected tissue specimens and no preop-
erative assessment of peri-tumor was reported. There is,
therefore, a need for a non-invasive technique to detect
the change of peri-tumor tissue for the purpose of provid-
ing more information about surgical scope.
Magnetic resonance imaging (MRI) has a high resolution
and can provide much more detailed images than mam-
mography and ultrasonography (US), which makes it a
widely-used tool for the diagnosis of breast lesions. How-
ever, the conventional breast MRI (plain MRI) is still a
morphological diagnostic technique which only provides
general anatomical information such as signal, shape, size
and location. One of the latest advancements in MRI tech-
nology is the application of diffusion-weighted imaging
(DWI). The principle underlying DWI is that the thermal
motion of water molecules in extracellular fluid enables
the acquisition of images that reflect both histological
structure and cellularity [10] and therefore it can detect
the changes of tissue structure at molecular level. It also
enables the quantitative evaluation of apparent diffusion
coefficient (ADC), which may be useful for distinguishing
malignant from benign tissues and monitoring therapeu-
tic outcome [11,12]. Compared with benign lesions, dif-
fusion of malignant tumors with high cellular tissue
decreased and the ADC value in malignant tumors is
lower than that of benign lesions [13-15]. Several latest
studies have shown that ADC has a potential for clinical
appreciation in differentiating benign and malignant
lesions with good specificity [16-19].
On the other side, DWI, based on its imaging mechanism,
could detect the changes of ADC in different tissues. Meas-
urement of the ADC provides a quantitative estimate of
the restrictive nature of the motion of water molecules
within tissue for each voxel in a diffusion-weighted image.
This study was thus designed to compare the ADC values
between malignant and benign lesions in breast and to
study the change of ADC values in peri-tumor tissues
through echo planar diffusion weighted imaging (EPI-
DWI). Our main aim was to study the DWI changes in tis-
sues adjacent to breast carcinoma, which would be help-
ful for the clinical surgeon to decide the scope and pattern
of operation.
Methods
This study was approved by the ethics committee of Xi'an
Jiaotong University and all patients gave written informed
consent before beginning the study.
Patients
54 cases with 57 breast lesions were examined by ultra-
sound and/or mammography before MRI from June 2006
to January 2007 in our hospital. No previous chemother-
apy or radiotherapy or surgery was administrated to these
patients. All patients were female and aged between 31
and 77 years (mean age: 46.3 years). All patients under-
went surgical resection and received definite pathological
diagnosis in our hospital.
Histological details
Findings were 22 benign lesions in 21 cases, including 14
breast fibroadenoma and 8 breast hyperplasia. Malignant
lesions totalled 35 in 33 patients, including 31 infiltrating
ductal carcinoma (IDC), 3 ductal carcinoma in situ
(DCIS) and 1 breast malignant phyllode. Lymph nodes
metastasis in malignant lesions was observed in 13 cases.
The mean of largest diameter of the benign lesions was
38.0 mm (from 8 to 106 mm) and that of breast cancer
was 28.4 mm (from 10 to 55 mm) and the largest diame-
ter of 1 breast malignant phyllode was 72.4 mm.
MRI protocols and imaging
MRI was performed with a 1.5 T MR system (Philips,
Gyroscan NT Release6, Netherlands) and a dedicated
phased-array bilateral breast coil, with the patient lying
prone and the breast in a holder to reduce motion. TheBMC Cancer 2009, 9:18 http://www.biomedcentral.com/1471-2407/9/18
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imaging protocols included a sagittal T1-weighted (T1-W)
water selective excitation (WATS) first field echo (FFE)
pulse sequence (matrix = 5122, slice thickness = 5 mm,
Flip angle(deg) = 25.00); a T2-weighted transverse (T2-W)
turbo spin-echo (TSE) pulse sequence (matrix = 5122,
slice thickness = 5 mm, Flip angle(deg) = 90.00); and an
Gradient echo planar image (EPI) DWI pulse sequence
(matrix = 128, FOV(mm) = 350.00, slice thickness = 5
mm, Flip angle(deg) = 90.00, diffusion mode = SE, NSA =
1). We modified b-values (b = 500 second/mm2 and 1000
second/mm2) to assume a better-fit convergence. Finally
we obtained two trace-weighted images and ADC maps
reconstruction. The analysis of magnetic resonance
images of the 57 lesions was shown in Table 1 (Figure 1,
2).
ADC value
All ADC values were calculated according to the formula:
ADC = -(1/b)In(S/So), where So and S are the signal
intensities in the region of interest (ROI), obtained with
different gradient factors (b values of 500, and 1000 sec-
ond/mm2). ADC distribution was demonstrated on an
ADC map created with Easy Vision Workstation (Philips,
Netherlands). The ROI was placed in and around the tar-
45-year-old woman with IDC in the left breast Figure 1
45-year-old woman with IDC in the left breast. A: WATS T1-weighted sagittal scan showed irregularly mass in the left 
breast with hyperintense signal. B: T2-weighted transverse scan showed the lesion was hypointense with spicule sign. C: EPI-
DWI sagittal scan showed lesion with slightly inhomogeneity hyperintense in DWI. D: Inhomogeneity hypointense was found in 
ADC map (b = 500) and the ADC was 0.94 ± 0.19 ± 10-3mm2/s.
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get lesion and the size of ROI in the lesion was 5 mm in
diameter. The protocol in measuring ADC values by two
readers was technologically same.
Statistical analysis
The Independent-Sample T-test and One-Way ANOVA
were used to determine statistical significance. P value <
0.05 was regarded as statistically significant. All above sta-
tistical analyses were performed using the SPSS11.5 soft-
ware package (SPSS Inc, Chicago, IL, USA). Cut-off values
between benign and malignant lesions were defined using
Receiver Operating Characteristic (ROC) curves.
Results
Comparison of ADC values between malignant lesions and 
benign lesions
Either b = 500 or b = 1000, the ADC values from reader 1
and reader 2 were highly consistent in all breast lesions:
for malignant lesions, when b = 500, P = 0.985 and when
b = 1000, P = 0.890; while for benign lesions, when b =
500, P = 0.839, and when b = 1000, P = 0.764. (all P >
36-year-old woman with fibroadenoma in right breast Figure 2
36-year-old woman with fibroadenoma in right breast. A: WATS T1-weighted sagittal scan showed a regular round 
slightly hypointense lesion. B: T2-weighted transverse scan showed a round and smooth hyperintense lesion in the right breast. 
C: EPI-DWI sagittal scan showed a hyperintense lesion in DWI. D: The isointense lesion was in ADC map (b = 1000) and the 
ADC was 2.44 ± 0.362×10-3mm2/s.
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0.05) (Table 2). Furthermore, there was no statistical dif-
ference between b = 500 and b = 1000 in malignant
lesions or benign lesions (both P > 0.05).
All data were entered into a spreadsheet and ROC meth-
odology was then used to decide the ADC value threshold
which could differentiate malignant lesions from benign
lesions. ROC curves from both readers were represented
in Figure. 3A and 3B. The threshold values of ADC were
1.24 ± 0.25 ± 10-3mm2/s (b = 500) and 1.20 ± 0.25 ± 10-
3mm2/s (b = 1000), respectively, and the summary of
ROC curves about their corresponding sensitivity and spe-
cificity were presented in table 3.
However, the ADC values of malignant lesions and
benign lesions were statistically different (both P < 0.001
for b = 500 and b = 1000, Table 4), which is obviously
higher in benign lesions than that in breast malignant
lesions, except for one malignant phyllode, whose ADC
value was very close to that of benign lesions.
ADC values among different layers and different directions 
around malignant lesions
Both readers further evaluated the ADC values of different
layers in different directions around the lesions (Figure 4).
Since the ADC map in our study was based on a sagittal
imaging, only one ADC map with the biggest diameter of
tumor was selected and the center of tumor was set as the
point to define the upper and lower in vertical direction as
well as anterior and posterior in horizontal direction and
the ROI distribution was symmetric in opposite direc-
tions. Since slice thickness of all above sequences was 5
Table 1: Analysis of magnetic resonance images of the 57 lesions
Classification No. WATS T1-weighted T2-weighted SE EPI-DWI ADC map
Malignant lesions 35
Breast cancer 33 Slightly hyperintense Hypointense Slightly inhomogeneity 
hyperintense
Inhomogeneity hypointense
1 Isointense Isointense Hyperintense Hyperintense
Breast sarcoma 1 Slightly hypointense Inhomogeneity hyperintense Slightly inhomogeneity 
hyperintense
Slightly inhomogeneity 
isointense
Benign lesion 22
Fibroadenoma 3 Homogeneity hypointense Homogeneity hyperintense Homogeneity hyperintense Homogeneity hyperintense
8 Homogeneity isointense Hypointense (2)
Isointense (4)
Hyperintense (2)
Hyperintense (7)
Isointense (1)
Isointense
3 Homogeneity hyperintense Hypointense Hyperintense (2)
Hypointense (1)
Isointense (2)
Inhomogeneity Hyperintense 
(1)
Breast hyperplasia 8D e n s i f i c a t i o n  o f  g l a n d  ( 6 )
Hypointense (1)
Isointense (1)
Hyperintense (2) Hyperintense (2) Hyperintense (1)
Hypointense (1)
Table 2: Average ADC values (×10-3mm2/s) measured by reader 1 and reader 2
Reader1 Reader2
b = 500 b = 1000 b = 500 b = 1000
Malignant lesions 1.04 ± 0.24a 1.01 ± 0.19b 1.04 ± 0.21 1.01 ± 0.22
Benign lesions 1.78 ± 0.31c 1.72 ± 0.36d 1.79 ± 0.28 1.75 ± 0.33
aP = 0.985, vs reader 2; bP = 0.890, vs reader 2; cP = 0.839, vs reader 2; dP = 0.764, vs reader 2.BMC Cancer 2009, 9:18 http://www.biomedcentral.com/1471-2407/9/18
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A: ROC curves for the ADC values from reader1 and reader2 (b = 500) Figure 3
A: ROC curves for the ADC values from reader1 and reader2 (b = 500). The area under the ROC curve (AUC) 
is 0.969(reader1) and 0.969(reader2). B: ROC curves for the ADC values from reader1 and reader2 (b = 1000). The area 
under the ROC curve (AUC) is 0.965 (reader1) and 0.967 (reader2).
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mm, from the anatomic border of malignant tumor out-
wards, ADC value of each ROI layer with a thickness of 5
mm was measured till skin or until the ADC values of
adjacent layers were very close to each other. The outer-
most layer in this study was layer 4.
Our results showed that the ADC of malignant lesions was
statistically lower than that of peri-tumor tissues (from
layer 1 to layer 4) in all directions (Figure 5) (P < 0.05),
while there was no statistical difference in ADC values
among the four directions within same layer.
Further detailed analysis showed that from layer 1 to layer
4, the ADC value increased gradually (Figure 6). The ADC
value of tumor lesion was significantly lower than that of
each layer of peri-tumor tissues, while the ADC value of
layer 1 was significantly lower than that of layer 2 (P <
0.05). However, there was no significant difference
between the ADC values of layer 2 and layer 3, or layer 3
and layer 4. Moreover, we also compared the ADC values
of different layers with the normal contralateral breast tis-
sue. We found that only ADC value of layer 1 was signifi-
cantly lower than that of contralateral breast tissue (P <
0.05).
Discussion
Despite the improvement in the detection of breast cancer
with the widespread application of mammography and
ultrasound, breast lesions still remain difficult to diagnose
and characterize, especially in dense fibroglandular
breasts. The main advantage of MRI in the breast is that
they can improve the detection and characterization of
multiple and/or small lesions even in the dense fibroglan-
dular breasts. However, the low specificity of MRI remains
a problem [20].
In recent years, the DWI has been extensively applied in
evaluating cerebral tumors and the correlation between
the ADC value and the cellular density has been verified.
Briefly, the higher the cellular density is, the lower the
ADC value will be in DWI, and vice versa [21]. For malig-
nant tumors, they have a relatively high cellular density
and therefore will produce a low ADC value in DWI, while
for benign lesion, its density is generally low and thus will
produce a high ADC value in DWI. Application of DWI in
the diagnosis of breast lesions has been reported recently
[14,16,22-24]. These studies showed that in malignant
breast tumors, the ADC was significantly lower than that
in benign tumors. These authors concluded that ADC
might help to differentiate benign and malignant lesions
with good specificity, and may increase the overall specif-
icity of breast MRI, which is consistent with our results.
In ROC curves, the specificity of the ADC is dependent on
the threshold value that determines the differentiation
between benign and malignant tumors. In our study, we
Table 3: The summary of ROC curve
Reader1 Reader2 Average of both readers
b = 500 b = 1000 b = 500 b = 1000 b = 500 b = 1000
Threshold(×10-3mm2/s) 1.29 ± 0.25 1.22 ± 0.25 1.39 ± 0.25 1.38 ± 0.25 1.24 ± 0.25 1.20 ± 0.25
Sensitivity 93% 93% 93% 97% 93% 96%
Specificity 91% 96% 96% 92% 100% 97%
Table 4: Values of ADC measured in breast lesions
Histology No. ADC(range) × 10-3mm2/s
b = 500
ADC(range) × 10-3mm2/s
b = 1000
Malignant lesions 35 1.04 ± 0.23a 1.01 ± 0.20b
ductal carcinoma in situ 3 0.99 ± 0.18 0.97 ± 0.21
infiltrating ductal carcinoma 31 1.04 ± 0.26 1.02 ± 0.19
Sarcoma 1 1.72 ± 0.21 1.72 ± 0.13
Benign lesions 22 1.79 ± 0.29 1.73 ± 0.34
aP = 0.000, vs benign lesions; bP = 0.000, vs benign lesions.BMC Cancer 2009, 9:18 http://www.biomedcentral.com/1471-2407/9/18
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obtained two threshold values: 1.24 ± 0.25 × 10-3mm2/s
(b = 500) with 93% sensitivity and 100% specificity; and
1.20 ± 0.25 × 10-3mm2/s (b = 1000) with 96% sensitivity
and 97% specificity. The threshold of ADC value in our
study was close to the data reported by Luo JD [16] (1.22
× 10-3mm2/s) and Rubesova E [14] (1.13 ± 0.10 × 10-
3mm2/s). The reason of difference was that in our study
we chose b = 500 and b = 1000 while in Luo JD's study, b
= 0 and b = 800 and in Rubesova E's study, three-dimen-
sional fast low-angle shot (3D-FLASH) with contrast
injection was applied. An exception in our study is that
one breast malignant phyllode had a high ADC value (b =
500, 1.72 ± 0.14 × 10-3mm2/s; b = 1000, 1.73 ± 0.14 × 10-
3mm2/s), which was similar to that in Woodhams R's
report (1.67 ± 0.59 × 10-3mm2/s) [12]. The reason of a
high ADC in tumor was that in this case the lesion was
mainly liposarcoma histologically and the liposarcoma,
similar to adipose tissue, has a relatively high ADC value.
Another important aim in our study is try to study the
DWI changes in tissues adjacent to breast carcinoma. It is
well known that over the past 30 years in the field of
breast carcinoma surgery, the extent of surgery has been
progressively reduced, which leads to less disfigurement
and a significant improvement in life quality of patients
[25]. From an oncological perspective, outcome of con-
servative breast surgery was found to be equally effective
when compared with mastectomy [26]. However, tumor
recurrence after breast-conserving surgery still remains a
problem [27]. Many studies [28-31] reported that obtain-
ing negative surgical margins in conservative breast sur-
gery influenced the incidence of local disease recurrence
and probably overall survival. Preoperative evaluation of
the change in peri-tumor tissue will plays an important
role for the success of conservative operation.
Nowadays in clinical works, the preoperative estimation
of the excision scope of breast tumor is generally made by
surgeon according to his own experience, based on the
results of mammography, ultrasound and conventional
MRI. However, because the capacity for malignant growth
is acquired by the stepwise accumulation of defects in spe-
cific genes regulating cell growth and tissue homeostasis
[32], the genetic and molecular alteration prior to pheno-
typic changes in peri-tumor tissues usually could not be
reflected by conventional mammography, ultrasound and
MRI examinations. On the other hand, although intraop-
erative pathological diagnosis was regarded as an impor-
This sagittal schematic drawing showed how we measured  the ADC values of tumor tissue and peri-tumor tissues Figure 4
This sagittal schematic drawing showed how we 
measured the ADC values of tumor tissue and peri-
tumor tissues. The red crooked line presented the breast 
tumor and the small circles of different colors from dark blue 
to light blue presented different layers of peri-tumor tissues 
with a diameter of 5 mm.
The ADC values (×10-3mm2/s) of tumor tissue and peri- tumor tissues in different directions Figure 5
The ADC values (×10-3mm2/s) of tumor tissue and 
peri-tumor tissues in different directions. The standard 
deviation (×10-3mm2/s) was as following: front: 0.418, back: 
0.509, upper: 0.289, blow: 0.374, central: 0.155.
0.9
1.1
1.3
1.5
1.7
1.9
2.1
2.3
center 1 2 3 4
Layer
A
D
C
 
v
a
l
u
e
The ADC values (×10-3mm2/s) of tumor tissue and peri- tumor tissues of different layers Figure 6
The ADC values (×10-3mm2/s) of tumor tissue and 
peri-tumor tissues of different layers. The standard 
deviation (×10-3mm2/s) was as following: tumor: 0.233, first 
layer: 0.257, second layer: 0.370, third layer: 0.382, fourth 
layer: 0.370.
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tant standard second only to routine paraffin section for
the evaluation of negative or positive margin of tumor, it
can only be performed approximately 30 minutes post
excision of the lesion and the decision must be made
intraoperatively [33-37]. Routine paraffin section diagno-
sis is the "gold standard", however, the data will be
decided after operation a couple of days. Therefore, it is
essential to explore new techniques that should be nonin-
vasive and could detect the change of peri-tumor tissue
before operation. For these reasons, DWI, due to its dis-
tinct characteristics mentioned above, might provide
some information on the microstructure change of breast
tissues and probably becomes a potentially valuable
method for evaluating the change of peri-tumor tissue in
breast carcinoma.
In our present study we first applied DWI to compare the
ADC value of malignant tumor with that of its peripheral
tissue. We found that from the parenchyma of tumor to its
peripheral tissue, which was layered with a thickness of 5
mm, the ADC values gradually increased and between the
innermost layer 1 and other outer layers, there was a sig-
nificant difference in their ADC values (P < 0.05), while
there was no difference from layer 2 to layer 4. Further
comparison study showed that only ADC value of layer 1
was significantly lower than that of normal contralateral
breast tissue. Although from layer 2 outwards, there was
no statistical difference among different layers, it can not
be concluded that the tissue in layer 2, or even outer lay-
ers, was completely normal, since the tumor intrude into
surrounding tissue with infiltrative growth pattern but we
considered each layer as a homogeneous tissue while we
performed statistical analysis.
Besides, since this work was basically a methodological
study and our aim was to study the change of ADC values
change in peri-tumor tissue by the novel MRI technique,
all the lesions recruited in our study were from mastec-
tomy and relatively large in size. Therefore, further
researches are needed to assess whether the results and
threshold in the present study could be also applied to the
smaller lesions.
Conclusion
In conclusion, our study showed that the ADC value was
a sensitive and specific parameter that can help to differ-
entiate benign and malignant breast lesions with a thresh-
old value of 1.24 ± 0.25 ± 10-3mm2/s (b = 500) and 1.20
± 0.25 ± 10-3mm2/s (b = 1000). Our results also showed
that the ADC values increased gradually from the tumor to
peri-tumor to normal tissues and there existed a region
with a thickness of about 5 mm surrounding the border of
tumor (by routine MRI), which has an abnormal ADC
value, while beyond this region, the ADC value of tissue
return to a normal range gradually.
Our next stage studies will include: 1) Measure ADC value
of each ROI layer with a thinner thickness to detect the
gradual change from carcinoma to normal tissue; 2) Com-
pare the examination of DWI with that of pathological
histology about the change of peri-tumor tissue in breast
carcinoma and study the correlation of diagnosis between
these two methods.
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